ARCHIVES

Selumetinib Displays Positive Results, 60% with Stable Disease

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013

NCI Gets Concept Approval for New Communications Network

May 27, 1988

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review

November 3, 1978